Lista de obras -

Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme

artículo científico publicado en 2020

Atrial fibrillation in cardiac resynchronization recipients with and without prior arrhythmic history. How much of arrhythmia is too much?

artículo científico publicado en 2015

CHA2DS2-VASc score risk factors as predictors of stroke after acute coronary syndrome: Can we really be sure there is no atrial fibrillation?

scientific article published on 06 January 2017

Can we rely on machines? Device-detected atrial high rates correspond well with atrial arrhythmias in cardiac resynchronization recipients

artículo científico publicado en 2015

Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

artículo científico publicado en 2019

Contrast-induced acute kidney injury in patients undergoing cardiac resynchronization therapy-incidence and prognostic importance. Sub-analysis of data from randomized TRUST CRT trial.

artículo científico publicado en 2014

Cryoballoon ablation of atrial fibrillation in patients with advanced systolic heart failure and cardiac implantable electronic devices

artículo científico publicado en 2018

Day by day telemetric care of patients treated with cardiac resynchronisation therapy: first Polish experience

artículo científico publicado en 2016

Device-related infective endocarditis in cardiac resynchronization therapy recipients - Single center registry with over 2500 person-years follow up.

artículo científico publicado en 2016

Do we need to monitor the percentage of biventricular pacing day by day?

artículo científico publicado en 2016

Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators.

artículo científico publicado en 2010

Effect of cardiac resynchronization on gradient reduction in patients with obstructive hypertrophic cardiomyopathy: preliminary study

artículo científico publicado en 2011

Efficacy of cardiac resynchronisation therapy in the treatment of end-stage inotrope-dependent heart failure patients.

artículo científico publicado en 2014

Factors determining the choice between subcutaneous or transvenous implantable cardioverter-defibrillators in Poland in comparison with other European countries: a sub-study of the European Heart Rhythm Association prospective survey

scientific article published on 09 August 2018

Ferritin as a potential biomarker of efficacy of treatment of atrial fibrillation - preliminary report

artículo científico publicado en 2017

Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the "Real World"

artículo científico publicado en 2017

Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community-Based Darlington Atrial Fibrillation Registry.

artículo científico publicado en 2017

Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries

scientific article published on 06 November 2019

Implantation Feasibility, Procedure-Related Adverse Events and Lead Performance During 1-Year Follow-Up in Patients Undergoing Triple-Site Cardiac Resynchronization Therapy: A Substudy of TRUST CRT Randomized Trial

artículo científico publicado en 2012

Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm.

artículo científico publicado en 2013

Many response criteria are poor predictors of outcomes after cardiac resynchronization therapy: validation using data from the randomized trial.

artículo científico publicado en 2013

Outcomes in patients undergoing cardiac resynchronisation therapy complicated by device-related infective endocarditis

scientific article published on 09 August 2018

Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up

artículo científico publicado en 2020

Polish and European management strategies in patients with atrial fibrillation. Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot)

artículo científico publicado en 2016

Prognostic Significance of Complex Ventricular Arrhythmias Complicating ST-Segment Elevation Myocardial Infarction.

artículo científico publicado en 2018

Prognostic Significance of Hyperuricemia in Patients with Different Types of Renal Dysfunction and Acute Myocardial Infarction Treated with Percutaneous Coronary Intervention

artículo científico publicado en 2010

Prognostic significance of HbA1c in patients with AMI treated invasively and newly detected glucose abnormalities

scientific article published on 11 March 2014

Quality of life in cardiac resynchronization recipients: association with response and impact on outcome.

artículo científico publicado en 2014

Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry.

artículo científico publicado en 2017

Risk stratification for complex ventricular arrhythmia complicating ST-segment elevation myocardial infarction

scientific article published on 01 December 2018

Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program

artículo científico publicado en 2019

Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry

artículo científico publicado en 2017

Should We Judge Stroke Risk by Static or Dynamic Risk Scores? A Focus on the Dynamic Nature of Stroke and Bleeding Risks in Patients With Atrial Fibrillation

artículo científico publicado en 2019

Stroke prevention strategies in high-risk patients with atrial fibrillation

artículo científico publicado en 2020

Successful implantation of leadless pacemakers in children: a case series

artículo científico publicado en 2020

The Incidence, Clinical Significance, and Treatment Effects of Depression in Cardiac Resynchronization Therapy Recipients.

artículo científico publicado en 2017

The impact of unsuccessful percutaneous coronary intervention on short- and long-term prognosis in STEMI and NSTEMI

artículo científico publicado en 2011

The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively

artículo científico publicado en 2012

The risk of stroke in patients with acute myocardial infarction treated invasively

artículo científico publicado en 2012

To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation

artículo científico publicado en 2016

Transseptal versus transaortic approach for radiofrequency ablation in patients with cardioverter–defibrillator and electrical storm

artículo científico publicado en 2010

Triple-Site Versus Standard Cardiac Resynchronization Therapy Study (TRUST CRT): Clinical Rationale, Design, and Implementation

artículo científico publicado en 2009

Trying to predict the unpredictable: Variations in device-based daily monitored diagnostic parameters can predict malignant arrhythmic events in patients undergoing cardiac resynchronization therapy

artículo científico publicado en 2014

Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes

artículo científico publicado en 2020

Lista de obras de

Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme

Atrial fibrillation in cardiac resynchronization recipients with and without prior arrhythmic history. How much of arrhythmia is too much?

CHA2DS2-VASc score risk factors as predictors of stroke after acute coronary syndrome: Can we really be sure there is no atrial fibrillation?

Can we rely on machines? Device-detected atrial high rates correspond well with atrial arrhythmias in cardiac resynchronization recipients

Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Contrast-induced acute kidney injury in patients undergoing cardiac resynchronization therapy-incidence and prognostic importance. Sub-analysis of data from randomized TRUST CRT trial.

Cryoballoon ablation of atrial fibrillation in patients with advanced systolic heart failure and cardiac implantable electronic devices

Day by day telemetric care of patients treated with cardiac resynchronisation therapy: first Polish experience

Device-related infective endocarditis in cardiac resynchronization therapy recipients - Single center registry with over 2500 person-years follow up.

Do we need to monitor the percentage of biventricular pacing day by day?

Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators.

Effect of cardiac resynchronization on gradient reduction in patients with obstructive hypertrophic cardiomyopathy: preliminary study

Efficacy of cardiac resynchronisation therapy in the treatment of end-stage inotrope-dependent heart failure patients.

Factors determining the choice between subcutaneous or transvenous implantable cardioverter-defibrillators in Poland in comparison with other European countries: a sub-study of the European Heart Rhythm Association prospective survey

Ferritin as a potential biomarker of efficacy of treatment of atrial fibrillation - preliminary report

Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the "Real World"

Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community-Based Darlington Atrial Fibrillation Registry.

Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries

Implantation Feasibility, Procedure-Related Adverse Events and Lead Performance During 1-Year Follow-Up in Patients Undergoing Triple-Site Cardiac Resynchronization Therapy: A Substudy of TRUST CRT Randomized Trial

Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm.

Many response criteria are poor predictors of outcomes after cardiac resynchronization therapy: validation using data from the randomized trial.

Outcomes in patients undergoing cardiac resynchronisation therapy complicated by device-related infective endocarditis

Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up

Polish and European management strategies in patients with atrial fibrillation. Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot)

Prognostic Significance of Complex Ventricular Arrhythmias Complicating ST-Segment Elevation Myocardial Infarction.

Prognostic Significance of Hyperuricemia in Patients with Different Types of Renal Dysfunction and Acute Myocardial Infarction Treated with Percutaneous Coronary Intervention

Prognostic significance of HbA1c in patients with AMI treated invasively and newly detected glucose abnormalities

Quality of life in cardiac resynchronization recipients: association with response and impact on outcome.

Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry.

Risk stratification for complex ventricular arrhythmia complicating ST-segment elevation myocardial infarction

Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program

Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry

Should We Judge Stroke Risk by Static or Dynamic Risk Scores? A Focus on the Dynamic Nature of Stroke and Bleeding Risks in Patients With Atrial Fibrillation

Stroke prevention strategies in high-risk patients with atrial fibrillation

Successful implantation of leadless pacemakers in children: a case series

The Incidence, Clinical Significance, and Treatment Effects of Depression in Cardiac Resynchronization Therapy Recipients.

The impact of unsuccessful percutaneous coronary intervention on short- and long-term prognosis in STEMI and NSTEMI

The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively

The risk of stroke in patients with acute myocardial infarction treated invasively

To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation

Transseptal versus transaortic approach for radiofrequency ablation in patients with cardioverter–defibrillator and electrical storm

Triple-Site Versus Standard Cardiac Resynchronization Therapy Study (TRUST CRT): Clinical Rationale, Design, and Implementation

Trying to predict the unpredictable: Variations in device-based daily monitored diagnostic parameters can predict malignant arrhythmic events in patients undergoing cardiac resynchronization therapy

Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes